SCM
VIR icon

Sterling Capital Management’s Vir Biotechnology VIR Stock Holding History

Sterling Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.7K Sell
3,093
-2,040
-40% -$16.3K ﹤0.01% 1871
2025
Q4 		$31K Sell
5,133
-1,012
-16% -$6.03K ﹤0.01% 2001
2025
Q3 		$35.1K Buy
6,145
+3,712
+153% +$19K ﹤0.01% 1895
2025
Q2 		$12.3K Buy
2,433
+867
+55% +$4.65K ﹤0.01% 1999
2025
Q1 		$10.1K Sell
1,566
-1,302
-45% -$11.6K ﹤0.01% 1859
2024
Q4 		$21.1K Buy
2,868
+2,549
+799% +$20.1K ﹤0.01% 1856
2024
Q3 		$2.39K Buy
+319
New +$2.77K ﹤0.01% 2103

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return